Unrecognized Tax Benefits of VERTEX PHARMACEUTICALS INC / MA from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
VERTEX PHARMACEUTICALS INC / MA quarterly Unrecognized Tax Benefits in USD history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • VERTEX PHARMACEUTICALS INC / MA Unrecognized Tax Benefits for the quarter ending 31 Dec 2025 was $852,100,000, a 21% increase year-over-year.
Source SEC data
View on sec.gov
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Change (%)

VERTEX PHARMACEUTICALS INC / MA Quarterly Unrecognized Tax Benefits (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $852,100,000 +$145,900,000 +21% 31 Dec 2025 10-K 13 Feb 2026 2025 FY
Q4 2024 $706,200,000 +$90,300,000 +15% 31 Dec 2024 10-K 13 Feb 2026 2025 FY
Q4 2023 $615,900,000 +$156,300,000 +34% 31 Dec 2023 10-K 13 Feb 2026 2025 FY
Q4 2022 $459,600,000 +$312,400,000 +212% 31 Dec 2022 10-K 13 Feb 2026 2025 FY
Q4 2021 $147,200,000 +$60,600,000 +70% 31 Dec 2021 10-K 13 Feb 2025 2024 FY
Q4 2020 $86,600,000 +$52,700,000 +155% 31 Dec 2020 10-K 15 Feb 2024 2023 FY
Q4 2019 $33,900,000 +$14,400,000 +74% 31 Dec 2019 10-K 10 Feb 2023 2022 FY
Q3 2019 $29,400,000 +$22,600,000 +332% 30 Sep 2019 10-Q 31 Oct 2019 2019 Q3
Q2 2019 $27,500,000 +$21,600,000 +366% 30 Jun 2019 10-Q 01 Aug 2019 2019 Q2
Q1 2019 $25,200,000 +$20,400,000 +425% 31 Mar 2019 10-Q 01 May 2019 2019 Q1
Q4 2018 $19,500,000 +$15,686,000 +411% 31 Dec 2018 10-K 09 Feb 2022 2021 FY
Q3 2018 $6,800,000 +$6,800,000 30 Sep 2018 10-Q 25 Oct 2018 2018 Q3
Q2 2018 $5,900,000 +$5,900,000 30 Jun 2018 10-Q 26 Jul 2018 2018 Q2
Q1 2018 $4,800,000 +$4,800,000 31 Mar 2018 10-Q 27 Apr 2018 2018 Q1
Q4 2017 $3,814,000 +$3,814,000 31 Dec 2017 10-K 11 Feb 2021 2020 FY
Q3 2017 $0 $0 30 Sep 2017 10-Q 30 Oct 2017 2017 Q3
Q2 2017 $0 -$400,000 -100% 30 Jun 2017 10-Q 28 Jul 2017 2017 Q2
Q1 2017 $0 -$400,000 -100% 31 Mar 2017 10-Q 28 Apr 2017 2017 Q1
Q4 2016 $0 -$425,000 -100% 31 Dec 2016 10-K 13 Feb 2020 2019 FY
Q3 2016 $0 -$900,000 -100% 30 Sep 2016 10-Q 31 Oct 2016 2016 Q3
Q2 2016 $400,000 -$500,000 -56% 30 Jun 2016 10-Q 01 Aug 2016 2016 Q2
Q1 2016 $400,000 -$500,000 -56% 31 Mar 2016 10-Q 03 May 2016 2016 Q1
Q4 2015 $425,000 -$455,000 -52% 31 Dec 2015 10-K 13 Feb 2019 2018 FY
Q3 2015 $900,000 -$4,800,000 -84% 30 Sep 2015 10-Q 30 Oct 2015 2015 Q3
Q2 2015 $900,000 -$2,100,000 -70% 30 Jun 2015 10-Q 04 Aug 2015 2015 Q2
Q1 2015 $900,000 -$1,700,000 -65% 31 Mar 2015 10-Q 04 May 2015 2015 Q1
Q4 2014 $880,000 -$1,144,000 -57% 31 Dec 2014 10-K 23 Feb 2017 2016 FY
Q3 2014 $5,700,000 30 Sep 2014 10-Q 06 Nov 2014 2014 Q3
Q2 2014 $3,000,000 30 Jun 2014 10-Q 31 Jul 2014 2014 Q2
Q1 2014 $2,600,000 31 Mar 2014 10-Q 05 May 2014 2014 Q1
Q4 2013 $2,024,000 -$2,082,000 -51% 31 Dec 2013 10-K 16 Feb 2016 2015 FY
Q4 2012 $4,106,000 -$254,000 -5.8% 31 Dec 2012 10-K 13 Feb 2015 2014 FY
Q4 2011 $4,360,000 +$1,986,000 +84% 31 Dec 2011 10-K 11 Feb 2014 2013 FY
Q4 2010 $2,374,000 31 Dec 2010 10-K 01 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.